Back to top
more

PerkinElmer, Inc. (PKI)

(Delayed Data from NYSE)

$96.59 USD

96.59
692,880

+1.71 (1.80%)

Updated May 3, 2019 04:03 PM ET

After-Market: $96.59 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

PerkinElmer (PKI) Tops Q3 Earnings Estimates

PerkinElmer (PKI) delivered earnings and revenue surprises of 4.95% and -2.16%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

PerkinElmer (PKI) to Report Q3 Earnings: What's in Store?

Top-line growth and robust performance at Diagnostics segment are likely to have aided PerkinElmer's (PKI) Q3 earnings. However, forex is likely to have been a dampener.

PerkinElmer (PKI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

PerkinElmer (PKI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Hold on to PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) is gaining steadily from the core Diagnostics segment, prudent acquisitions and margin expansion. However, forex volatility remains a concern.

Bruker To Buy Freiberg Instruments' Magnettech EPR Business

The Freiberg Instruments' Magnettech EPR business acquisition is expected to boost Bruker's (BRKR) BioSpin business by complementing its existing range of EPR offerings.

Here's Why You Should Retain PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) is gaining steadily from core Diagnostics segment, prudent acquisitions and margin expansion. However, forex volatility remains a concern.

Why Is PerkinElmer (PKI) Down 8.4% Since Last Earnings Report?

PerkinElmer (PKI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Aniruddha Ganguly headshot

Scientific Instruments Industry Outlook: Prospects Look Good

The Zacks Instruments - Scientific industry is benefiting from solid prospects in emerging markets, robust end-market demand and increasing spending on health care.

PerkinElmer (PKI) Q2 Earnings and Revenues Miss Estimates

Higher revenues and growth in Diagnostics segment benefit PerkinElmer's (PKI) Q2 earnings. However, forex remains a woe.

PerkinElmer (PKI) Misses Q2 Earnings and Revenue Estimates

PerkinElmer (PKI) delivered earnings and revenue surprises of -0.99% and -1.06%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

What's in the Offing for PerkinElmer's (PKI) Earnings in Q2?

Top-line growth and robust performance at Diagnostics segment are likely to aid PerkinElmer's (PKI) Q2 earnings. However, forex is likely to be a dampener.

PerkinElmer (PKI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

PerkinElmer (PKI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Hold PerkinElmer (PKI) Stock for Now

PerkinElmer (PKI) raises earnings per share guidance for 2019.

PerkinElmer (PKI) Down 9.2% Since Last Earnings Report: Can It Rebound?

PerkinElmer (PKI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Hold on to PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) is gaining steadily from its core Diagnostics segment, prudent acquisitions and margin expansion. However, forex volatility remains a concern.

PerkinElmer (PKI) Beats on Q1 Earnings, Hikes '19 Guidance

PerkinElmer's (PKI) Q1 earnings gain from top-line growth, solid show by Diagnostics segment and strong margins. However, negative currency movement remains a headwind.

Can Diagnostic Revenues Fuel PerkinElmer's (PKI) Q1 Earnings?

Strength in PerkinElmer's (PKI) core Diagnostics business is expected to drive Q1 results amid foreign exchange woes.

PerkinElmer (PKI) Reports Next Week: Wall Street Expects Earnings Growth

PerkinElmer (PKI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Varian Medical (VAR) to Report Q2 Earnings: What's in Store?

Varian Medical (VAR) expects to gain significantly from APAC and EMEA regions in fiscal Q2.

What's in Store for Edwards Lifesciences' (EW) Q1 Earnings?

Edwards Lifesciences (EW) expects to gain from core Critical Care product group in Q1.

Will Instruments Drive Intuitive Surgical (ISRG) Q1 Earnings?

Intuitive Surgical's (ISRG) Systems and Services revenues are likely to boost Q1 results.

3 Reasons Why Investors Should Retain PerkinElmer (PKI) Stock

PerkinElmer (PKI) has been gaining investor confidence on consistently positive results.

PerkinElmer (PKI) Q4 Earnings Beat, Diagnostics Grows Y/Y

PerkinElmer's (PKI) fourth-quarter 2018 results gain from solid segmental contributions.

Cerner (CERN) to Report Q4 Earnings: What's in the Cards?

Cerner's (CERN) fourth-quarter 2018 results are likely to be hurt by year-over-year decline in bookings; Q4 guidance promising.

Can BD Medical Drive Becton, Dickinson's (BDX) Q1 Earnings?

Becton, Dickinson's (BDX) solid fiscal first-quarter preliminary results boost optimism in the stock.